Candesartan Cilexetil Tablet
Product Images NDC 62559-687

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil (NDC 62559-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

16mg-50k (16mg 50k)

Label for Candesartan Cilexetil Tablets 16 mg, a prescription oral tablet. The label indicates the quantity of 50,000 tablets, storage conditions (20° to 25°C), and states it is for repackaging only. Manufactured by AstraZeneca AB, Sweden, and distributed by ANI Pharmaceuticals, Inc., Baudette, MN. It includes an NDC barcode and space for manufacturing, expiration dates, and lot number.*

FDA Label Image

32mg-25k (32mg 25k)

This packaging label is for Candesartan Cilexetil Tablets 32 mg. It indicates a quantity of 25,000 tablets with storage instructions to keep between 20° to 25°C (68° to 77°F) and to keep the container tightly closed. The tablets are manufactured by AstraZeneca AB in Sweden and distributed by ANI Pharmaceuticals, Inc. in Baudette, MN. The label includes a barcode, NDC 62559-689-98, and notes it is for repackaging only.*

FDA Label Image

4mg-50k (4mg 50k)

Label for Candesartan Cilexetil Tablets 4 mg, oral dosage form, with a package quantity of 50,000 tablets. Manufactured by AstraZeneca AB in Sweden and distributed by ANI Pharmaceuticals, Inc., Baudette, MN. The label advises storage at 20° to 25°C and notes the product is for repackaging only. Includes barcode and Rx only designation.*

FDA Label Image

8mg-50k (8mg 50k)

Label for Candesartan Cilexetil Tablets 8 mg, showing an oral tablet formulation with an NDC of 62559-687-99 and a quantity of 50,000 tablets. The label notes storage instructions and indicates the product is for repackaging only. Manufactured by AstraZeneca AB in Sweden and distributed by ANI Pharmaceuticals, Inc., Baudette, MN.*

FDA Label Image

Logo (Ani 01)

FDA Label Image

Logo (Ani)

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of Candesartan cilexetil, showing the molecular arrangement and highlighting the site of ester hydrolysis.*

FDA Label Image

Figure 1 Graph (Image 02)

A forest plot chart showing hazard ratios with 95% confidence intervals for various patient subgroups comparing Candesartan cilexetil to placebo. Subgroups include age, sex, race, NYHA class, LVEF, medical history (diabetes, hypertension, MI, atrial fibrillation), and use of medications like ACE inhibitors, beta-blockers, spironolactone, diuretics, digitalis, aspirin, and lipid-lowering drugs. The plot visually compares the relative risk between treatment and placebo across these categories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.